Citation Impact
Citing Papers
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Endometriosis: a high-risk population for major chronic diseases?
2015
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
1991
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Risk of cancer in women receiving hormone replacement therapy
1989
Cancer burden in the year 2000. The global picture
2001 Standout
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)
2003
Global Cancer Statistics, 2002
2005 Standout
Venous thromboembolism and cancer
1998
Prognosis of Cancers Associated with Venous Thromboembolism
2000 Standout
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
The Risk of Breast Cancer after Estrogen and Estrogen–Progestin Replacement
1989
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
2001
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy
1999
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Renal-Cell Carcinoma
1996 Standout
Relation of body mass index to cancer risk in 362,552 Swedish men
2006
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Hormone Replacement Therapy and the Risk for First Hip Fracture
1990
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Hormone Replacement Therapy and Cardiovascular Disease: The Case for a Randomized Controlled Trial
2007
Osteoporosis: now and the future
2011 Standout
Hormone Replacement Therapy and Prevention of Nonvertebral Fractures
2001
External review and validation of the Swedish national inpatient register
2011 Standout
Cancer and interstitial lung disease
2004
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
The changing global patterns of female breast cancer incidence and mortality
2004
The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement
1992
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Estrogen-Progestin Replacement Therapy and Endometrial Cancer
1997
Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins
1999
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Osteoclast differentiation and activation
2003 StandoutNature
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
1999
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women
1997
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Survival after the Diagnosis of Hyperparathyroidism: A Population-based Study
1998
Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer
1991
Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates
2004
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
1995
Nutrition and renal cell cancer
1996
Production and Actions of Estrogens
2002 Standout
Fracture of the distal forearm as a forecaster of subsequent hip fracture: A population-based cohort study with 24 years of follow-up
1993
Obesity and renal cell cancer – a quantitative review
2001
Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk
2004
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 Standout
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Secondary osteoporosis and the risk of distal forearm fractures in men and women
2002
Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women
2003
The Risk of Endometrial Neoplasia and Treatment with Estrogens and Estrogen ‐ Progestogen Combinations: First results of a cohort study after one to four completed years of observation
1986
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
2003 Standout
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women
1996
Primary Prevention of Ischemic Stroke
2001
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Bone Resorption by Osteoclasts
2000 StandoutScience
Risk factors, falls, and fracture of the distal forearm in Manchester, UK.
1996
Reduced Incidence and Severity of Antigen-induced Autoimmune Diseases in Mice Lacking Interferon Regulatory Factor-1
1997
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
2000
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation
1999
Smoking and fracture risk: a meta-analysis
2004
Postmenopausal Hormone Therapy and Risk of Stroke
2001
A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer
1991
A global view on cancer incidence and national levels of the human development index
2016
Endometriosis
2020 Standout
Primary Prevention of Ischemic Stroke
2001
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Therapeutic Approaches to Bone Diseases
2000 Science
Cytochrome P450 and Chemical Toxicology
2007
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of I. Persson being referenced
Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
1989
The aetiology and pathogenesis of human breast cancer
1995
S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians
1996
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
2006
Risk factors for fractures of the distal forearm: A population-based case-control study
1994
The risk of hip fractures in patients with primary hyperparathyroidism: a population‐based cohort study with a follow‐up of 19 years
1993
Trends in breast cancer incidence in Sweden 1958-1988 by time period and birth cohort
1993
Recent trends in breast cancer incidence in Sweden
1998
Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density.
1997
Hormone replacement therapy and risk of hip fracture: population based case-control study
1998
Risk Factors for Breast and Endometrial Cancer in a Cohort of Women Treated with Menopausal Oestrogens
1988
A novel mutant variant of the CYP2D6 gene (CYP2D617) common in a black African population: association with diminished debrisoquine hydroxylase activity
1996
Variation in the Efficacy of Hormone Replacement Therapy in the Prevention of Hip Fracture
1998
In VitroKinetics of Two HumanCYP1A1Variant Enzymes Suggested to Be Associated with Interindividual Differences in Cancer Susceptibility
1997
Cytokine Gene Expression During Infeetion of Miee Lacking CD4 and/or CD8 with Trypanosoma cruzi
1995
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
1993
Practice and Patterns of Estrogen Treatment in Climacteric Women in a Swedish Population
1983
Characteristics of Estrogen‐Treated Women
1983
89204333 Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy
1990
The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study.
1994
Scleroderma and malignancy: an epidemiological study.
1993
Cohort study of oestrogen treatment and the risk of endometrial cancer: Evaluation of method and its applicability
1983